Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Israel Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20151
20162
20173
20182
20191
20204
20218
20223
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting7
Recruiting7
Terminated7
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie9
Novartis Pharmaceuticals5
Pfizer3
Merck Sharp & Dohme LLC2
Anza Therapeutics, Inc.1
AstraZeneca1
Bayer1
Biomica Ltd.1
Boehringer Ingelheim1
Calico Life Sciences LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung32
Neoplasms13
Colorectal Neoplasms8
Melanoma8
Triple Negative Breast Neoplasms8
Carcinoma, Renal Cell6
Squamous Cell Carcinoma of Head and Neck6
Breast Neoplasms4
Stomach Neoplasms4
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.